A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(21 sites)

Belgium

Universitair Ziekenhuis Leuven, Leuven

Brazil

Instituto de Medicina Integral Professor Fernando Figueira, Recife

Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro

Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo

France

CHRU Lille, Lille

Hopital trousseau- APHP, Paris

Hungary

Semmelweis Egyetem, Budapest

Israel

Sheba Medical Center, Ramat Gan

Italy

Mangiagalli Clinic IRCCS Ca Granda Foundation Ospedale Maggiore Policlinico, Milan

Fondazione Policlinico Universitario A Gemelli IRCCS, Rome

Norway

Haukeland University Hospital, Bergen

Oslo University Hospital HF Ulleval sykehus, Oslo

Universitetssykehuset Nord-Norge HF, Tromsø

St. Olavs Hospital, Trondheim

Slovakia

Univerzitna nemocnica L. Pasteura Kosice, Košice

Univerzitná nemocnica Martin, Martin

Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky

Slovenia

Univerzitetni klinicni center Ljubljana, Ljubljana

Spain

Hosp. Virgen Del Rocio, Seville

Sweden

Karolinska Universitetssjukhuset Huddinge, Stockholm

Switzerland

Centre Hospitalier Universitaire Vaudois CHUV, Lausanne